CVS to Pay $315M to Settle Opioid Prescribing Allegations

· Health · United States

CVS has agreed to pay $315 million to settle allegations that it filled unnecessary opioid prescriptions that prosecutors say fueled the opioid epidemic. A company spokesperson said CVS admitted to no wrongdoing and "strongly disagreed" with the case's claims. The settlement adds to the long list of legal penalties pharmacies and drugmakers have faced over their role in the US opioid crisis, which has prompted widespread litigation and billions of dollars in payouts across the industry. For pharmacy chains, the case underscores continuing legal exposure over dispensing practices and the controls they are expected to maintain when filling controlled-substance prescriptions.

Why it matters：It extends the wave of opioid-related penalties to a major pharmacy chain, reinforcing expectations for stricter dispensing controls across the industry.

Key points

  • The settlement is $315 million.
  • Prosecutors alleged CVS filled unnecessary opioid prescriptions.
  • CVS denied wrongdoing and said it strongly disagreed with the claims.

Sources (original reporting)

More stories from this day